Sunil Healthcare Ltd

Tue 1/09/2026,15:14:31 | NSE : SUNLOC

₹79.01-1.75 (-2.17%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 81.00

Previous Close

₹ 80.76

Volume

1398

Mkt Cap ( ₹ Cr)

₹ 81.02

High

₹ 82.00

Low

₹ 77.01

52 Week High

₹ 81.00

52 Week Low

₹ 67.50

Book Value Per Share

₹ 68.33

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Sunil Healthcare Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Sunil Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sunil Healthcare - Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th August 2026

    13 Aug 2026, 7:00PM Outcome of Board meeting held on 13th August 2026
  • Sunil Healthcare - Approved Un-Audited Financial Results For The 1St Quarter Of FY 2026-27 Ended On 30.06.2026

    13 Aug 2026, 6:57PM approved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.2026
  • Sunil Healthcare - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 13.08.2026 Pursuant T

    31 Jul 2026, 11:56AM Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and
  • Sunil Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    7 Jul 2026, 8:10PM As of June 2026, 73.53% is owned by Indian Promoters and 26.47% by Public. <p align=justify> Top three Promoters holding highest number of shares of S
  • Sunil Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Jul 2026, 4:31PM Compliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations
  • Sunil Healthcare - Special Window For Transfer And Dematerialisation ('Demat') \r\nOf Physical Securities\r\n

    30 Jun 2026, 4:01PM Special window for Transfer and Dematerialisation of Physical Securities
  • Sunil Healthcare posts Q4 net loss of Rs 6.82 cr

    1 Jun 2026, 8:00PM The company reported standalone net loss during the quarter stood at Rs 6.82 crore compared to net profit of Rs 0.25 crore in the previous year quarte

Key fundamentals

Evaluate the intrinsic value of Sunil Healthcare Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 123.6209 142.2971 140.1949 96.9397 89.0123
Liabilities 123.6209 142.2971 140.1949 96.9397 89.0123
Equity 10.2548 10.2548 10.2548 10.2548 10.2548
Gross Profit 13.96 11.8697 4.2842 19.3069 17.8114
Net Profit -5.3021 0.2051 -2.1078 6.9769 6.7768
Cash From Operating Activities 22.1528 11.5375 -14.3492 7.1288 21.8933
NPM(%) -6.04 0.24 -2.35 6.23 5.82
Revenue 87.7192 83.4211 89.6875 111.8295 116.3729
Expenses 73.7592 71.5514 85.4033 92.5226 98.5615
ROE(%) -7.56 0.29 -3 9.95 9.67

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sunil Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 871.70 -2.92 22.05 46.05 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 108.77 -0.28 1553.86 167.81 0.39 0.00
Vaishali Pharma Ltd 8.03 -0.37 25.09 1052.70 15.42 0.00
Astec Lifesciences Ltd 562.40 0.30 0.00 179.79 -363.14 0.00

Company Info

Sunloc, a leading brand of Empty Hard Gelatin Capsules, comes from Sunil Healthcare Ltd. Having started its operations over four decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets. Established in 1976 Located in Alwar (Rajasthan), 100 miles south of New Delhi, Capital of India. 2nd largest empty hard-shell gelatin (EHG) capsule producer in India. Introduced double-lock, triple lock and multi groove Capsules. Production capacity of 10.25 billion capsules/year on 22 fully automatic production lines. GMP Certificate as per NSF/IPEC/WHO-GMP/ANSI 363 Guideline & USFDA Certif¡cate - DMF No. - 18735, TYPE IV. 2014 -Sunil Healthcare Ltd shares are listed and admitted to dealings on the Exchange -Sunil Healthcare Limited (SHL) has been bestowed with the award for "Outstanding Contribution to Indias Pharmaceutical Exports during the year FY 2012-2013. 2015 -ICRA upgrades long term rating of Sunil Healthcare to BBB -Sunil Healthcare Ltd has "Award for the Best Use of Six Sigma in Healthcare by ABP News". 2016 -Sunil Healthcare sets-up wholly owned subsidiary in USA by the name of Sunil Healthcare North America LLC. 2017 -The company's Food Division has been awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Sunloc, a leading brand of Empty Hard Gelatin Capsules, comes from Sunil Healthcare Ltd. Having started its operations over four decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets. Established in 1976 Located in Alwar (Rajasthan), 100 miles south of New Delhi, Capital of India. 2nd largest empty hard-shell gelatin (EHG) capsule producer in India. Introduced double-lock, triple lock and multi groove Capsules. Production capacity of 10.25 billion capsules/year on 22 fully automatic production lines. GMP Certificate as per NSF/IPEC/WHO-GMP/ANSI 363 Guideline & USFDA Certif¡cate - DMF No. - 18735, TYPE IV. 2014 -Sunil Healthcare Ltd shares are listed and admitted to dealings on the Exchange -Sunil Healthcare Limited (SHL) has been bestowed with the award for "Outstanding Contribution to Indias Pharmaceutical Exports during the year FY 2012-2013. 2015 -ICRA upgrades long term rating of Sunil Healthcare to BBB -Sunil Healthcare Ltd has "Award for the Best Use of Six Sigma in Healthcare by ABP News". 2016 -Sunil Healthcare sets-up wholly owned subsidiary in USA by the name of Sunil Healthcare North America LLC. 2017 -The company's Food Division has been awarded the prestigious 'Export Award' as 'Top Most Exporter under Cashew nut and Allied products from New Delhi.

Parent Organisation

Sunil Healthcare Ltd.

Founded

05/02/1973

Managing Director

NSE Symbol

SUNLOCEQ

FAQ